Mass Spectrometry & Advances in the Clinical Lab (MSACL)

MSACL is committed to the advancement of mass spectrometry and other advanced technologies, including data science, in the clinical laboratory through education and training of practitioners, physicians, laboratory scientists, industrial scientists, and health care professionals involved in patient care and management. MSACL supports the development of new technologies to be used in laboratory medicine; including diagnosis, treatment, and prognosis of clinical disorders.

MSACL was incorporated in May 2009 as non-profit and is tax exempt under 501(c)(3). The association's mission is to further the accumulation and sharing of expertise in the area of mass spectrometry and advanced technologies for use in the clinical laboratory with the goal of improving patient care. As part of this mission the association hosts MSACL conferences in the US and Europe, as well as supporting educational activities in Asia. MSACL also supports and manages the society's Journal of Mass Spectrometry & Advances in the Clinical Lab.

Objectives & Target Audience:
The objective of MSACL is to support the enhancement of patient care using technology & data science. The target audience includes pathologists, clinical laboratory directors, clinical scientists, and researchers, as well as laboratory diagnostic providers. This programs provided by MSACL are beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.